LUPKYNIS: payments to doctors
Payments that named LUPKYNIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $6.4M
- Providers
- 11,723
- Transactions
- 62,902
- Average per transaction
- $102
The per-transaction average — $102 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,723 providers the average total is $550, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Aurinia Pharma U.S., Inc. | $6,446,854 | 100.0% |